New research claims that nearly four million people in the UK may be unaware they are at high risk of heart disease. An University of Oxford team screened more than 71,000 people aged over 18 across England, Wales and Scotland.
Approximately 31 million people in the European Union are suffering from diabetes, a devastating disease with severe consequences for patients and their families, but also for the society at large and the economic prosperity of Europe. This week EH Online will focus on innovative strategies in diabetes care and on new management systems to support physicians and patients alike. Moreover, we will…
Researchers at Linköping University and Uppsala University in Sweden can show that accumulation of protein aggregatess, amyloid, in the transplanted cells may be causing their death. With the aid of their results, physicians can enhance survival of islets transplants and improve treatment of type 1 diabetes.
Optimal treatment of diabetes is very difficult to achieve since many obstacles have to be overcome such as expensive treatments, poor patient compliance or insufficient datac. With these challenges in mind, a new research project titled "Computerassisted Diabetes Risk Management (CDRM)" was put in place to examine how eHealth solutions can improve diabetes care.
According to a study conducted by researchers at the University of Zurich and the Zurich University Hospital the answer is: Yes. They demonstrated that one injection per month sufficed to improve blood sugar levels significantly. Even more: The insulin production of the patients improved.
The German Federal Ministry of Education and Research recently agreed funding for a diabetes competence network — the first diabetes mellitus project to be funded by the ministry's new “Health Research — Research for People” programme.
ESC speaker John Cleland from the University of Hull, UK, sumed up the latest treatment available for patients with diabetes mellitus and expressed his worries about side-effects and efficacy of available anti-diabetic drugs. If you want to read his ESC abstract, just click the “read more” button.
Bayer HealthCare Diabetes Care unveiled the new CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.
Transition Therapeutics Inc. announced that the first patient has been dosed in a Phase 2 clinical study of gastrin analogue, TT-223, in patients with type 2 diabetes. Gastrin based therapies are an emerging class of potential disease-modifying treatments for patients with diabetes.
Last week the English government closed its consultation on the effectiveness of vascular checks for high-risk people aged 40-74. Would this help? Experts from New Zealand and the WHO say "yes". Others argue that public health approaches targeting the whole population are both: cheaper and more effective than tablets.
French findings support the notion that gastric bypass can rapidly reverse diabetes symptoms' a side-effect that lap-band surgery does not show. The benefit results from a new-found element of glucose production by the intestine which also increases insulin sensitivity and lowers blood sugar.
The new Contour blood glucose meter from Bayer HealthCare Diabetes Care promises enhanced testing features that can be personalised to meet diabetics individual treatments. The firm has also redesigned the Microlet 2 lancing system.
Countries vary widely in their capacity to manage hypertension, but globally the majority of diagnosed hypertensives is inadequately controlled. Not treated it can cause cardiovascular disease (CVD), myocardial infarction and stroke. According to the WHO, hypertension is estimated to cause 4.5% of the current global disease burden and is as prevalent in many developing countries as in the…
Unlike regular laboratory analyses, which is performed by clinical pathologists and technicians in the clinical laboratory, Point of Care Testing (POCT) are devices to perform laboratory analyses in the vicinity of the patient by the attending physician or nurses.
Roche reports that, using its NimbleGen CGH arrays, researchers* have identified a recurrent reciprocal genomic rearrangement of chromosomal region 17q12 in foetal samples with congenital anomalies that is also associated with paediatric renal disease and epilepsy.
The probability of woman of suffering from cardiovascular diseases is often underestimated. A recent study evaluated the risk of nearly 9.000 women in the U.S. screened for heart-health risk: one in five women had a higher risk than measured by a frequently used predictor.
Tiny lipid-shelled microbubbles injected in vessels may serve as an new ultrasound contrast agent to evaluate microvascular blood flow. By this microbubbles US-researcher devised a ultrasound imaging technique that can spot early signs of PAD.
Diabetes fires researchers imagination: Two scientists at the University of Michigan Kellogg Eye Center developed a new screening device that gives early warnings of diabetes and its vision complications within five minutes.
The ankle brachial index, a ratio of blood pressure measurements used to indicate the risk of peripheral artery disease and atherosclerosis, may be useful to improve the accuracy of cardiovascular risk prediction, according to a meta-analysis of previous studies.
This week not only one but rather two studies report about a new and independent marker that is associated with type 2 diabetes. The protein that is called fetuin-A is produced in the liver and secreted to the blood stream also indicates a higher risk of developing diabetes disease.
Bayer loves sports. Therefore it developes medical devices to work under extremes. Recently extrem-athlete and diabetic Geri Winkler conquered the Seven Summits - a group of mountains comprising the highest peaks on each of the seven continents. The blood glucose monitoring system from Bayer HealthCare is always with him.
Siemens Healthcare Diagnostics will showcase the combined strengths of Diagnostics Products Corporation (DPC), Bayer HealthCare Diagnostics and Dade Behring.
During the 2nd European Workshop on Diabetes, hosted by Bayer HealthCare Diabetes Care, experts called for uncompromising management of diabetes.
Prevalence of adult obesity has increased three-fold since 1990. The prevalence of childhood obesity has increased ten times since 1970. In Europe, almost 50% of adults and over 20% of children are overweight. A third of these are obese. Conservative estimates show that, in Europe, about 100 million adults and 10 million children are obese. Obesity is accountable for c. one million deaths…
